Pfizer warns of lung cancer with inhaled insulin
NEW YORK (Reuters) - Pfizer Inc and Nektar Therapeutics said on Wednesday clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to end talks with potential partners to market the product. 7 months ago
Reuters Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook
How do these dangerous drugs continue to receive regulator approval?
I don't mean to downplay the danger of the drug - there may very well be serious risks associated with it. However the article states that the few cases of lung disease that did develop were in smokers - the contribution of this history cannot be overlooked.